Drug Type Therapeutic vaccine |
Synonyms Melanoma vaccine + [2] |
Target- |
Mechanism Immunostimulants, T lymphocytes stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Phase 2 | - | - |
Phase 3 | 355 | mFOLFOX6 | (rqrlgfsowh): HR = 0.72 (95% CI, 0.41 - 1.26), P-Value = 0.876 View more | Negative | 20 May 2016 | ||
mFOLFOX6 and Bev (5mg/kg) | |||||||
Phase 2 | 13 | (sjrprixejn) = iitxtsjrzv klwkzwnoju (zoxurmnvvu ) View more | - | 20 May 2012 | |||
Phase 2 | Breast Cancer Neoadjuvant | - | Nab-P 100 mg/m2 IV + CBP AUC=2 IV + BEV 10 mg/kg | (yvnllgysse) = wsxvtdiajb qvxlvxfzef (lqievbsmvj ) | - | 20 May 2010 |